Added to YB: 2025-12-17
Pitch date: 2025-10-31
LENZ [bearish]
LENZ Therapeutics, Inc.
+59.35%
current return
Author Info
No bio for this author
Company Info
LENZ Therapeutics, Inc. operates as a biopharmaceutical company that focuses on the development and commercialization of therapies to improve vision in the United States.
Market Cap
$403.0M
Pitch Price
$29.64
Price Target
N/A
Dividend
N/A
EV/EBITDA
-3.01
P/E
-6.11
EV/Sales
11.53
Sector
Pharmaceuticals
Category
N/A
LENZ Therapeutics, Inc. - $LENZ (short)
LENZ short: Vizz eye drops launched 4wks ago w/ <4K prescriptions vs 700K+ expected 2026. Intense redness, headaches plague users; prescribers burned by prior Vuity failures. Orasis competitor Qlosi backed by JNJ launched 6mo earlier w/o side effects. Need 2M+ Rxs for breakeven vs $100M annual commercial spend. Zero intrinsic value.
Read full article (6 min)